Shiru
Latest round
- Series B
Last raised
- Nov 2024
Total raised
- $37M
Investors
- 16
About Shiru
Shiru, Inc.Founded in 2019 and headquartered in Berkeley, US, Shiru, Inc. develops sustainable ingredient solutions. The company has undergone no significant pivots in its core business strategy. Jasmin Hume, the founder and current CEO, drives the company's vision.Shiru specializes in innovative ingredient solutions across the food, personal care, and agriculture sectors, with a focus on natural proteins that enhance product functionality while promoting sustainability. Their offerings include OleoPro™, a structured fat alternative to replicate animal fat properties, and uPro™, a texturizing protein for diverse food applications. Shiru's proprietary Flourish™ platform expedites ingredient discovery, transitioning products from concept to market readiness within 1-2 years, significantly reducing the traditional discovery period.Shiru generates revenue through partnerships with businesses seeking to commercialize their innovative ingredients. The model operates on a B2B basis, with manufacturers and product developers engaging Shiru for products like OleoPro™ and uPro™, alongside other clean-label alternatives. Pricing reflects the specialized nature of these offerings and is customized based on client needs.In November 2024, Shiru, Inc. The company aims to develop new products and expand into specific markets, although detailed release dates or targeted regions have not been disclosed.
Who invested in Shiru
16 investors across 3 rounds
See all investors in Shiru
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shiru
Who invested in Shiru?
Shiru has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shiru raised?
Shiru has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Shiru last raise money?
Shiru's most recent round on record is a Series B, in Nov 2024.
What does Shiru do?
Shiru is a biotechnology company.
Where is Shiru headquartered?
Shiru is headquartered in Berkeley, US.
Which VCs invest in companies like Shiru?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Shiru's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shiru? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.